{"id": "article-31002_0", "title": "Vascular Dementia -- Continuing Education Activity", "content": "Vascular dementia is among the most common\u00a0etiologies of\u00a0major\u00a0neurocognitive\u00a0disorder (MND), affecting primarily older adults (>65), and it is the leading\u00a0nondegenerative\u00a0cause of dementia. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) subsumes all dementing diseases under the syndromic term MND.\u00a0MND requires an acquired decline in one or more cognitive domains, eg, attention, memory, executive function, language, or visuospatial ability, and a decline in functional independence.", "contents": "Vascular Dementia -- Continuing Education Activity. Vascular dementia is among the most common\u00a0etiologies of\u00a0major\u00a0neurocognitive\u00a0disorder (MND), affecting primarily older adults (>65), and it is the leading\u00a0nondegenerative\u00a0cause of dementia. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) subsumes all dementing diseases under the syndromic term MND.\u00a0MND requires an acquired decline in one or more cognitive domains, eg, attention, memory, executive function, language, or visuospatial ability, and a decline in functional independence."}
{"id": "article-31002_1", "title": "Vascular Dementia -- Continuing Education Activity", "content": "A significant practice gap for clinicians in managing vascular dementia lies in the absence of approved disease-modifying treatments, necessitating a focus on effectively controlling vascular risk factors. The gap involves a lack of widespread awareness and implementation of preventative measures to mitigate the development of vascular dementia, such as addressing hypertension, blood glucose levels, lipid profiles, diet, BMI, physical activity, and smoking status. Additionally, clinicians must navigate the off-label use of acetylcholinesterase inhibitors and memantine\u00a0and individualize\u00a0cognitive rehabilitation strategies.\u00a0This activity narrows\u00a0this practice gap by improving clinician competency\u00a0when implementing\u00a0interdisciplinary care, individualized treatment discussions, and patient-centered recommendations for managing\u00a0vascular dementia.", "contents": "Vascular Dementia -- Continuing Education Activity. A significant practice gap for clinicians in managing vascular dementia lies in the absence of approved disease-modifying treatments, necessitating a focus on effectively controlling vascular risk factors. The gap involves a lack of widespread awareness and implementation of preventative measures to mitigate the development of vascular dementia, such as addressing hypertension, blood glucose levels, lipid profiles, diet, BMI, physical activity, and smoking status. Additionally, clinicians must navigate the off-label use of acetylcholinesterase inhibitors and memantine\u00a0and individualize\u00a0cognitive rehabilitation strategies.\u00a0This activity narrows\u00a0this practice gap by improving clinician competency\u00a0when implementing\u00a0interdisciplinary care, individualized treatment discussions, and patient-centered recommendations for managing\u00a0vascular dementia."}
{"id": "article-31002_2", "title": "Vascular Dementia -- Continuing Education Activity", "content": "Objectives: Identify the underlying pathophysiology and etiology of vascular dementia to diagnose affected individuals accurately. Differentiate vascular dementia from other major neurocognitive disorders, such as Alzheimer disease and Lewy body dementia. Implement current evidence-based approaches to develop targeted treatment plans for affected individuals. Apply interprofessional team strategies for improving care coordination to advance the treatment of vascular dementia and improve outcomes. Access free multiple choice questions on this topic.", "contents": "Vascular Dementia -- Continuing Education Activity. Objectives: Identify the underlying pathophysiology and etiology of vascular dementia to diagnose affected individuals accurately. Differentiate vascular dementia from other major neurocognitive disorders, such as Alzheimer disease and Lewy body dementia. Implement current evidence-based approaches to develop targeted treatment plans for affected individuals. Apply interprofessional team strategies for improving care coordination to advance the treatment of vascular dementia and improve outcomes. Access free multiple choice questions on this topic."}
{"id": "article-31002_3", "title": "Vascular Dementia -- Introduction", "content": "Vascular dementia is among the most common\u00a0etiologies of major neurocognitive disorder (MND), affecting primarily older adults (>65), and it is the leading\u00a0nondegenerative\u00a0cause of dementia. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) subsumes all dementing diseases under the syndromic term MND.\u00a0MND requires an acquired decline in one or more cognitive domains, eg, attention, memory, executive function, language, or visuospatial ability, and a decline in functional independence.", "contents": "Vascular Dementia -- Introduction. Vascular dementia is among the most common\u00a0etiologies of major neurocognitive disorder (MND), affecting primarily older adults (>65), and it is the leading\u00a0nondegenerative\u00a0cause of dementia. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) subsumes all dementing diseases under the syndromic term MND.\u00a0MND requires an acquired decline in one or more cognitive domains, eg, attention, memory, executive function, language, or visuospatial ability, and a decline in functional independence."}
{"id": "article-31002_4", "title": "Vascular Dementia -- Introduction", "content": "Cardiovascular risk factors\u2014smoking, hypertension, hyperlipidemia, diabetes, and atrial fibrillation\u2014commonly underlie vascular dementia. Diagnosis relies upon a thorough history and physical/neurologic\u00a0(including mental status) examination. Neuroimaging increases the precision of the diagnosis. Treatment is supportive in the ongoing absence of disease-modifying medications for vascular dementia approved by regulatory bodies.", "contents": "Vascular Dementia -- Introduction. Cardiovascular risk factors\u2014smoking, hypertension, hyperlipidemia, diabetes, and atrial fibrillation\u2014commonly underlie vascular dementia. Diagnosis relies upon a thorough history and physical/neurologic\u00a0(including mental status) examination. Neuroimaging increases the precision of the diagnosis. Treatment is supportive in the ongoing absence of disease-modifying medications for vascular dementia approved by regulatory bodies."}
{"id": "article-31002_5", "title": "Vascular Dementia -- Etiology", "content": "Vascular dementia is distinguished from other forms of MND in that it results from brain ischemia or hemorrhage and\u00a0not\u00a0from one or more underlying neurodegenerative proteinopathies. However, the temporal relationship\u00a0between causative ischemic events and subsequent cognitive decline may be subtle or go unnoticed. The pathogenesis of vascular dementia is understood as follows: vascular risk factors lead to cerebrovascular disease that, in turn, causes brain injury; the resulting disruption of cognitive networks culminates in vascular dementia.", "contents": "Vascular Dementia -- Etiology. Vascular dementia is distinguished from other forms of MND in that it results from brain ischemia or hemorrhage and\u00a0not\u00a0from one or more underlying neurodegenerative proteinopathies. However, the temporal relationship\u00a0between causative ischemic events and subsequent cognitive decline may be subtle or go unnoticed. The pathogenesis of vascular dementia is understood as follows: vascular risk factors lead to cerebrovascular disease that, in turn, causes brain injury; the resulting disruption of cognitive networks culminates in vascular dementia."}
{"id": "article-31002_6", "title": "Vascular Dementia -- Etiology", "content": "Recent reports in the neuropathological and neuropsychological literature posit\u00a0that vascular dementia and\u00a0Alzheimer disease\u00a0frequently co-occur, making so-called pure cases of either condition\u00a0comparatively rare. Indeed, cerebrovascular dysfunction\u00a0may potentiate\u00a0Alzheimer disease\u00a0pathology, and pathological changes in\u00a0Alzheimer disease may, likewise, induce vascular dysfunction. [1]", "contents": "Vascular Dementia -- Etiology. Recent reports in the neuropathological and neuropsychological literature posit\u00a0that vascular dementia and\u00a0Alzheimer disease\u00a0frequently co-occur, making so-called pure cases of either condition\u00a0comparatively rare. Indeed, cerebrovascular dysfunction\u00a0may potentiate\u00a0Alzheimer disease\u00a0pathology, and pathological changes in\u00a0Alzheimer disease may, likewise, induce vascular dysfunction. [1]"}
{"id": "article-31002_7", "title": "Vascular Dementia -- Epidemiology", "content": "Historically, the incidence of vascular dementia has been believed to increase, more or less linearly, with age. However, recent work is beginning to challenge this received knowledge: one report with more than 1.4 million person-years of follow-up concluded that cerebrovascular disease is no longer a risk factor for dementia among older adults. [2] Estimates vary, but consensus traditionally considers vascular dementia the second most common cause of dementia\u2014after AD\u2014in North America and Europe, accounting for as much as 15 to 20% of clinically diagnosed MND cases. The disease burden may be higher in Asia and some developing countries. [3] Estimates are complicated, however, by the prevalence of mixed dementias, often vascular dementia in combination with\u00a0Alzheimer disease\u00a0pathology, with considerably less than 15% of cases arising from \u201cpure\u201d vascular pathologies in neuropathological studies. [4]", "contents": "Vascular Dementia -- Epidemiology. Historically, the incidence of vascular dementia has been believed to increase, more or less linearly, with age. However, recent work is beginning to challenge this received knowledge: one report with more than 1.4 million person-years of follow-up concluded that cerebrovascular disease is no longer a risk factor for dementia among older adults. [2] Estimates vary, but consensus traditionally considers vascular dementia the second most common cause of dementia\u2014after AD\u2014in North America and Europe, accounting for as much as 15 to 20% of clinically diagnosed MND cases. The disease burden may be higher in Asia and some developing countries. [3] Estimates are complicated, however, by the prevalence of mixed dementias, often vascular dementia in combination with\u00a0Alzheimer disease\u00a0pathology, with considerably less than 15% of cases arising from \u201cpure\u201d vascular pathologies in neuropathological studies. [4]"}
{"id": "article-31002_8", "title": "Vascular Dementia -- Pathophysiology", "content": "Neuropathologic studies illustrate vascular dementia's high degree of heterogeneity, with multiple and overlapping types of cerebrovascular disease damaging multiple sites in the vascular tree. [5] Thus, etiologic precision in vascular dementia is complicated by the varying distributions of vascular involvement and their sequelae.\u00a0Historically, multiple and overlapping descriptive terms have been applied to vascular dementia; the continuing absence of any formal consensus-based clinical diagnostic criteria for vascular dementia has underscored the resulting nosological confusion.\u00a0Cardiovascular risk factors for vascular dementia include smoking, hyperlipidemia, hypertension, diabetes, atrial fibrillation, obesity, and physical inactivity, among others. Disparities in the prevalence of these risk factors may appear linked to race, but evidence is mounting that they likely arise instead from social determinants of health. [6]", "contents": "Vascular Dementia -- Pathophysiology. Neuropathologic studies illustrate vascular dementia's high degree of heterogeneity, with multiple and overlapping types of cerebrovascular disease damaging multiple sites in the vascular tree. [5] Thus, etiologic precision in vascular dementia is complicated by the varying distributions of vascular involvement and their sequelae.\u00a0Historically, multiple and overlapping descriptive terms have been applied to vascular dementia; the continuing absence of any formal consensus-based clinical diagnostic criteria for vascular dementia has underscored the resulting nosological confusion.\u00a0Cardiovascular risk factors for vascular dementia include smoking, hyperlipidemia, hypertension, diabetes, atrial fibrillation, obesity, and physical inactivity, among others. Disparities in the prevalence of these risk factors may appear linked to race, but evidence is mounting that they likely arise instead from social determinants of health. [6]"}
{"id": "article-31002_9", "title": "Vascular Dementia -- Pathophysiology", "content": "A brief\u00a0pr\u00e9cis of patterns of damage in the vascular tree that can result in cognitive impairment include:", "contents": "Vascular Dementia -- Pathophysiology. A brief\u00a0pr\u00e9cis of patterns of damage in the vascular tree that can result in cognitive impairment include:"}
{"id": "article-31002_10", "title": "Vascular Dementia -- Pathophysiology", "content": "Atherosclerosis of large feeding arteries, often associated with smoking and hyperlipidemia, can cause territorial infarcts via cerebrovascular arterial occusion or thromboembolism, resulting in the classic \"step-wise\" cognitive and functional decline of vascular dementia.", "contents": "Vascular Dementia -- Pathophysiology. Atherosclerosis of large feeding arteries, often associated with smoking and hyperlipidemia, can cause territorial infarcts via cerebrovascular arterial occusion or thromboembolism, resulting in the classic \"step-wise\" cognitive and functional decline of vascular dementia."}
{"id": "article-31002_11", "title": "Vascular Dementia -- Pathophysiology", "content": "Arteriolosclerosis, mainly linked to hypertension, can cause occlusive disease of small arteries that feed deep, penetrating structures, leading to lacunar infarcts, central hemorrhage, and cerebral microbleeds.", "contents": "Vascular Dementia -- Pathophysiology. Arteriolosclerosis, mainly linked to hypertension, can cause occlusive disease of small arteries that feed deep, penetrating structures, leading to lacunar infarcts, central hemorrhage, and cerebral microbleeds."}
{"id": "article-31002_12", "title": "Vascular Dementia -- Pathophysiology", "content": "Microvascular disease, most closely associated with diabetes, commonly disrupts metabolic function at the capillary level.", "contents": "Vascular Dementia -- Pathophysiology. Microvascular disease, most closely associated with diabetes, commonly disrupts metabolic function at the capillary level."}
{"id": "article-31002_13", "title": "Vascular Dementia -- Pathophysiology", "content": "Finally, the APOE \u03b54 genotype and cerebral amyloid angiopathy (in which amyloid-\u03b2\u00a0accumulates primarily in pial and cortical arteries and capillaries, causing lobar hemorrhage, cortical microinfarcts, and white matter hyperintensities) are also risk factors for vascular cognitive impairment and dementia.", "contents": "Vascular Dementia -- Pathophysiology. Finally, the APOE \u03b54 genotype and cerebral amyloid angiopathy (in which amyloid-\u03b2\u00a0accumulates primarily in pial and cortical arteries and capillaries, causing lobar hemorrhage, cortical microinfarcts, and white matter hyperintensities) are also risk factors for vascular cognitive impairment and dementia."}
{"id": "article-31002_14", "title": "Vascular Dementia -- Pathophysiology", "content": "Mixed vascular disease is more likely to cause cognitive and functional decline than pure atherosclerosis or arteriolosclerosis. [5]", "contents": "Vascular Dementia -- Pathophysiology. Mixed vascular disease is more likely to cause cognitive and functional decline than pure atherosclerosis or arteriolosclerosis. [5]"}
{"id": "article-31002_15", "title": "Vascular Dementia -- History and Physical", "content": "Diagnosis of vascular dementia requires a thorough history and physical/neurologic examination, including mental status. An overview of management, with guidance for the importance of mood and function, can be found in the American Academy of Neurology's (AAN) set of clinical quality measures for managing dementia. [7] Interviewing the care partner can provide salient supplemental details about history and current functioning, as care partners often\u00a0possess\u00a0additional details and, as the care partner, they will become an integral part of the patient-partner dyad. However, note that it is never acceptable to rely solely on information from the care partner, assuming that the actual patient lacks all insight or concern about their clinical situation. The history and physical should include:", "contents": "Vascular Dementia -- History and Physical. Diagnosis of vascular dementia requires a thorough history and physical/neurologic examination, including mental status. An overview of management, with guidance for the importance of mood and function, can be found in the American Academy of Neurology's (AAN) set of clinical quality measures for managing dementia. [7] Interviewing the care partner can provide salient supplemental details about history and current functioning, as care partners often\u00a0possess\u00a0additional details and, as the care partner, they will become an integral part of the patient-partner dyad. However, note that it is never acceptable to rely solely on information from the care partner, assuming that the actual patient lacks all insight or concern about their clinical situation. The history and physical should include:"}
{"id": "article-31002_16", "title": "Vascular Dementia -- History and Physical", "content": "A review of any vascular risk factors present\u2014including their duration, severity, and response to current pharmacologic treatment or lifestyle changes\u2014is an essential starting place. History should also be reviewed for previous cardiac surgeries or interventions for peripheral vascular disease.", "contents": "Vascular Dementia -- History and Physical. A review of any vascular risk factors present\u2014including their duration, severity, and response to current pharmacologic treatment or lifestyle changes\u2014is an essential starting place. History should also be reviewed for previous cardiac surgeries or interventions for peripheral vascular disease."}
{"id": "article-31002_17", "title": "Vascular Dementia -- History and Physical", "content": "Details should be sought about the patterns of cognitive difficulty, especially noting dysexecutive patterns or problems with attention, as these may be salient clues about underlying vascular dementia, compared to Alzheimer disease, where memory and word-finding difficulty usually predominate. Temporal association between cognitive/functional change and any ischemic/hemorrhagic insult should be sought. Descriptions of progression patterns are also important, with slow progression suggestive of subcortical vascular disease or possible Alzheimer disease/mixed pathology and a pattern of step-wise progression suggestive of possible underlying lacunar or territorial infarction(s).", "contents": "Vascular Dementia -- History and Physical. Details should be sought about the patterns of cognitive difficulty, especially noting dysexecutive patterns or problems with attention, as these may be salient clues about underlying vascular dementia, compared to Alzheimer disease, where memory and word-finding difficulty usually predominate. Temporal association between cognitive/functional change and any ischemic/hemorrhagic insult should be sought. Descriptions of progression patterns are also important, with slow progression suggestive of subcortical vascular disease or possible Alzheimer disease/mixed pathology and a pattern of step-wise progression suggestive of possible underlying lacunar or territorial infarction(s)."}
{"id": "article-31002_18", "title": "Vascular Dementia -- History and Physical", "content": "Social history should be reviewed for past or current tobacco use,\u00a0obesity, physical activity habits, and social networks.", "contents": "Vascular Dementia -- History and Physical. Social history should be reviewed for past or current tobacco use,\u00a0obesity, physical activity habits, and social networks."}
{"id": "article-31002_19", "title": "Vascular Dementia -- History and Physical", "content": "Family history should be sought for any form of dementia, but especially if thought to have been related to cerebrovascular disease.", "contents": "Vascular Dementia -- History and Physical. Family history should be sought for any form of dementia, but especially if thought to have been related to cerebrovascular disease."}
{"id": "article-31002_20", "title": "Vascular Dementia -- History and Physical", "content": "Medication review is vital to ascertain the use of medications to modify vascular risk factors and seek medications that are relatively contraindicated in older adults with cognitive concerns. [8]", "contents": "Vascular Dementia -- History and Physical. Medication review is vital to ascertain the use of medications to modify vascular risk factors and seek medications that are relatively contraindicated in older adults with cognitive concerns. [8]"}
{"id": "article-31002_21", "title": "Vascular Dementia -- History and Physical", "content": "Mood should be assessed for complicating symptoms of anxiety or depression. In particular, depression at midlife can act as a risk factor for later-life dementia, and later-life depression can be seen as a dementia prodrome. [9]", "contents": "Vascular Dementia -- History and Physical. Mood should be assessed for complicating symptoms of anxiety or depression. In particular, depression at midlife can act as a risk factor for later-life dementia, and later-life depression can be seen as a dementia prodrome. [9]"}
{"id": "article-31002_22", "title": "Vascular Dementia -- History and Physical", "content": "Functional ability for both instrumental (ie, cooking, driving, financial assistance, and medication management) and more basic activities of daily living (ie, dressing, bathing, and toileting) should be assessed\u00a0using activity questionnaires with demonstrated reliability and validity in dementia care. [10]", "contents": "Vascular Dementia -- History and Physical. Functional ability for both instrumental (ie, cooking, driving, financial assistance, and medication management) and more basic activities of daily living (ie, dressing, bathing, and toileting) should be assessed\u00a0using activity questionnaires with demonstrated reliability and validity in dementia care. [10]"}
{"id": "article-31002_23", "title": "Vascular Dementia -- History and Physical", "content": "The general physical examination of the older adult with possible vascular dementia should seek findings\u00a0suggesting\u00a0significant underlying cardiovascular disease. Pulse and blood pressure must be checked at every visit. Extremity examination should seek signs of peripheral vascular disease, eg, decreased skin temperature, brittle/shiny skin on the legs and feet, and weak pulses in the legs and feet; pitting lower extremity edema may indicate heart failure. Examination of the fundus may reveal signs of hypertensive retinopathy.", "contents": "Vascular Dementia -- History and Physical. The general physical examination of the older adult with possible vascular dementia should seek findings\u00a0suggesting\u00a0significant underlying cardiovascular disease. Pulse and blood pressure must be checked at every visit. Extremity examination should seek signs of peripheral vascular disease, eg, decreased skin temperature, brittle/shiny skin on the legs and feet, and weak pulses in the legs and feet; pitting lower extremity edema may indicate heart failure. Examination of the fundus may reveal signs of hypertensive retinopathy."}
{"id": "article-31002_24", "title": "Vascular Dementia -- History and Physical", "content": "The cardiopulmonary examination is essential to assess for arrhythmia (especially the irregularly irregular rhythm that indicates atrial fibrillation), carotid bruit indicating possible atherosclerosis and evidence of fluid overload on pulmonary examination. On neurological examination, the aim is to unearth signs of focal neurological deficit: most commonly encountered are upper motor neuron patterns of facial weakness, hemiparesis, hemisensory loss, or visual field cuts. Spasticity or increased deep tendon reflexes may point to a prior neurological insult. Evidence of gait impairment, bradykinesia, and rigidity should also be sought.", "contents": "Vascular Dementia -- History and Physical. The cardiopulmonary examination is essential to assess for arrhythmia (especially the irregularly irregular rhythm that indicates atrial fibrillation), carotid bruit indicating possible atherosclerosis and evidence of fluid overload on pulmonary examination. On neurological examination, the aim is to unearth signs of focal neurological deficit: most commonly encountered are upper motor neuron patterns of facial weakness, hemiparesis, hemisensory loss, or visual field cuts. Spasticity or increased deep tendon reflexes may point to a prior neurological insult. Evidence of gait impairment, bradykinesia, and rigidity should also be sought."}
{"id": "article-31002_25", "title": "Vascular Dementia -- History and Physical", "content": "As with all MND presentations, the cognitive assessment is the most important element of the initial clinical evaluation. As noted, the underlying site of vascular injury often yields typical patterns of cognitive impairment. The Vascular Impairment of Cognition Classification Consensus Study (VICCS) [11] posited the existence of\u00a04\u00a0phenotypic subtypes, noting that any\u00a01 of the\u00a04 has the potential for (or likely has) underlying mixed pathology: Subcortical ischemic vascular dementia : this phenotype is typically characterized by a slowly progressive decline in the speed of information processing, complex attention, and other executive abilities (eg, working memory, set-shifting, planning, organizing, and self-monitoring/awareness). Most commonly, the underlying pathophysiology is either (1) hypertension-induced arteriolosclerosis of long, penetrating\u00a0vessels causing chronic ischemia of periventricular and deep white matter or (2) diabetes-induced microvascular disease.", "contents": "Vascular Dementia -- History and Physical. As with all MND presentations, the cognitive assessment is the most important element of the initial clinical evaluation. As noted, the underlying site of vascular injury often yields typical patterns of cognitive impairment. The Vascular Impairment of Cognition Classification Consensus Study (VICCS) [11] posited the existence of\u00a04\u00a0phenotypic subtypes, noting that any\u00a01 of the\u00a04 has the potential for (or likely has) underlying mixed pathology: Subcortical ischemic vascular dementia : this phenotype is typically characterized by a slowly progressive decline in the speed of information processing, complex attention, and other executive abilities (eg, working memory, set-shifting, planning, organizing, and self-monitoring/awareness). Most commonly, the underlying pathophysiology is either (1) hypertension-induced arteriolosclerosis of long, penetrating\u00a0vessels causing chronic ischemia of periventricular and deep white matter or (2) diabetes-induced microvascular disease."}
{"id": "article-31002_26", "title": "Vascular Dementia -- History and Physical", "content": "Poststroke dementia : VICCS criteria carry forward older definitions here, requiring as they do that there be a history of actual stroke, with cognitive deficits emerging as early as immediately after the insult but not later than six (6) months. Cortical and deep brain structures known to have significant cognitive sequelae after stroke include the angular gyrus, thalamus, basal forebrain, basal ganglia, posterior cerebral artery territory (including the hippocampus, a central structure for memory and navigation), and anterior cerebral artery territory. [12] Multi-infarct dementia : VICCS defines this phenotype as one of multiple large cortical infarcts, usually arising from\u00a0territorial infarcts\u00a0caused by cerebrovascular arterial occlusion or thromboembolism. Cognitive evaluation may reveal cortical signs such as apraxia, aphasia, visual field cuts, or sensorimotor phenomena of hemineglect.", "contents": "Vascular Dementia -- History and Physical. Poststroke dementia : VICCS criteria carry forward older definitions here, requiring as they do that there be a history of actual stroke, with cognitive deficits emerging as early as immediately after the insult but not later than six (6) months. Cortical and deep brain structures known to have significant cognitive sequelae after stroke include the angular gyrus, thalamus, basal forebrain, basal ganglia, posterior cerebral artery territory (including the hippocampus, a central structure for memory and navigation), and anterior cerebral artery territory. [12] Multi-infarct dementia : VICCS defines this phenotype as one of multiple large cortical infarcts, usually arising from\u00a0territorial infarcts\u00a0caused by cerebrovascular arterial occlusion or thromboembolism. Cognitive evaluation may reveal cortical signs such as apraxia, aphasia, visual field cuts, or sensorimotor phenomena of hemineglect."}
{"id": "article-31002_27", "title": "Vascular Dementia -- History and Physical", "content": "Mixed dementia : Mixed dementia most commonly denotes a combination of vascular dementia and AD pathologies, although other MND combinations are possible. Such patients may even present with what appears to be a purely amnestic syndrome suggestive of AD; neuroimaging and, increasingly, biomarkers may help distinguish the two.", "contents": "Vascular Dementia -- History and Physical. Mixed dementia : Mixed dementia most commonly denotes a combination of vascular dementia and AD pathologies, although other MND combinations are possible. Such patients may even present with what appears to be a purely amnestic syndrome suggestive of AD; neuroimaging and, increasingly, biomarkers may help distinguish the two."}
{"id": "article-31002_28", "title": "Vascular Dementia -- History and Physical", "content": "The initial evaluation of a patient with possible cognitive impairment of vascular origin must include a formal cognitive assessment. In current practice, an emerging consensus supports the preferential use of the Montreal Cognitive Assessment (MoCA) over the use of the Mini-Mental State Examination (MMSE), as the former is better able to assess executive function and the latter possesses troublesome ceiling effects and cultural biases; both instruments have copyrights that are infrequently observed. However, the MoCA is insufficiently sensitive to slowed informational processing and visual memory impairments, and its sensitivity to right-hemisphere lesions is notably poor. [13] Some evidence suggests that other assessments, eg, the Memory and Executive Screening, may have superior performance. [14]", "contents": "Vascular Dementia -- History and Physical. The initial evaluation of a patient with possible cognitive impairment of vascular origin must include a formal cognitive assessment. In current practice, an emerging consensus supports the preferential use of the Montreal Cognitive Assessment (MoCA) over the use of the Mini-Mental State Examination (MMSE), as the former is better able to assess executive function and the latter possesses troublesome ceiling effects and cultural biases; both instruments have copyrights that are infrequently observed. However, the MoCA is insufficiently sensitive to slowed informational processing and visual memory impairments, and its sensitivity to right-hemisphere lesions is notably poor. [13] Some evidence suggests that other assessments, eg, the Memory and Executive Screening, may have superior performance. [14]"}
{"id": "article-31002_29", "title": "Vascular Dementia -- Evaluation", "content": "The standard workup for vascular dementia includes neuroimaging, laboratory assessment, and, if at all possible, neuropsychological testing.", "contents": "Vascular Dementia -- Evaluation. The standard workup for vascular dementia includes neuroimaging, laboratory assessment, and, if at all possible, neuropsychological testing."}
{"id": "article-31002_30", "title": "Vascular Dementia -- Evaluation -- Laboratory\u00a0Evaluation", "content": "Laboratory assessment  should include basic labs, such as a complete blood count and a comprehensive metabolic panel. Unless there is suspicion after a medical history review, there is no\u00a0need to obtain testing for c-reactive protein, HIV, or treponemal antibodies. In addition to basic laboratory tests, obtaining vitamin B12 and homocysteine levels is recommended. Homocysteine, in particular, has been associated with an increased risk of vascular dementia. [15]", "contents": "Vascular Dementia -- Evaluation -- Laboratory\u00a0Evaluation. Laboratory assessment  should include basic labs, such as a complete blood count and a comprehensive metabolic panel. Unless there is suspicion after a medical history review, there is no\u00a0need to obtain testing for c-reactive protein, HIV, or treponemal antibodies. In addition to basic laboratory tests, obtaining vitamin B12 and homocysteine levels is recommended. Homocysteine, in particular, has been associated with an increased risk of vascular dementia. [15]"}
{"id": "article-31002_31", "title": "Vascular Dementia -- Evaluation -- Neuroimaging", "content": "Neuroimaging is essential for making rigorous diagnoses of MND. MRI is the preferred imaging modality because its different sequences and orientations provide essential insights in evaluating cognitive impairment. Contrast is not necessary unless one is concerned about possible hemorrhage or infection. Noncontrast MRI has multiple sequences and many different orientations. The salient\u00a0sequences for a dementia evaluation include: T1-weighted sequence : This is the preferred sequence for evaluating brain anatomy and atrophy patterns, which can be regional. Coronal sequences are\u00a0best for assessing hippocampal atrophy, which can be important for determining the likelihood of mixed Alzheimer disease and vascular dementia, as hippocampal volume should be all or primarily preserved in cases of \"pure\" vascular dementia. Generalized cerebral atrophy can be associated with underlying cardiovascular disease; therefore, such atrophy has low specificity for vascular dementia. [16]", "contents": "Vascular Dementia -- Evaluation -- Neuroimaging. Neuroimaging is essential for making rigorous diagnoses of MND. MRI is the preferred imaging modality because its different sequences and orientations provide essential insights in evaluating cognitive impairment. Contrast is not necessary unless one is concerned about possible hemorrhage or infection. Noncontrast MRI has multiple sequences and many different orientations. The salient\u00a0sequences for a dementia evaluation include: T1-weighted sequence : This is the preferred sequence for evaluating brain anatomy and atrophy patterns, which can be regional. Coronal sequences are\u00a0best for assessing hippocampal atrophy, which can be important for determining the likelihood of mixed Alzheimer disease and vascular dementia, as hippocampal volume should be all or primarily preserved in cases of \"pure\" vascular dementia. Generalized cerebral atrophy can be associated with underlying cardiovascular disease; therefore, such atrophy has low specificity for vascular dementia. [16]"}
{"id": "article-31002_32", "title": "Vascular Dementia -- Evaluation -- Neuroimaging", "content": "FLAIR (fluid-attenuated inversion recovery sequences): White matter ischemia causes damaged areas to appear bright on FLAIR; FLAIR is also a helpful sequence for identifying lacunar infarcts. The severity of white matter ischemia can be graded using the Fazekas scale; [17] using this scale, severe white matter disease has been reported\u00a0to predict rapid global functional decline. [18] Gradient echo (GRE) or susceptibility-weighted\u00a0imaging (SWI) : Either of these sequences can aid in identifying cerebral microbleeds. Such bleeds in deep subcortical structures usually arise from underlying hypertension; when microbleeds occur at the gray-white junction, in the subarachnoid space, or along the surface of the cortex (superficial siderosis), underlying CAA is usually the culprit. Diffusion-weighted imaging (DWI) : This sequence brightly and whitely highlights acute stroke and should always be reviewed.", "contents": "Vascular Dementia -- Evaluation -- Neuroimaging. FLAIR (fluid-attenuated inversion recovery sequences): White matter ischemia causes damaged areas to appear bright on FLAIR; FLAIR is also a helpful sequence for identifying lacunar infarcts. The severity of white matter ischemia can be graded using the Fazekas scale; [17] using this scale, severe white matter disease has been reported\u00a0to predict rapid global functional decline. [18] Gradient echo (GRE) or susceptibility-weighted\u00a0imaging (SWI) : Either of these sequences can aid in identifying cerebral microbleeds. Such bleeds in deep subcortical structures usually arise from underlying hypertension; when microbleeds occur at the gray-white junction, in the subarachnoid space, or along the surface of the cortex (superficial siderosis), underlying CAA is usually the culprit. Diffusion-weighted imaging (DWI) : This sequence brightly and whitely highlights acute stroke and should always be reviewed."}
{"id": "article-31002_33", "title": "Vascular Dementia -- Evaluation -- Neuropsychological Testing", "content": "Neuropsychological testing is invaluable for fleshing out the full scope of cognitive and behavioral changes in all cases of MND, including vascular dementia. [13] Domain-specific cognitive assessment can aid in distinguishing vascular dementia from\u00a0Alzheimer disease based on neuropsychological profile; mixed dementia is more challenging to assess, making longitudinal assessment necessary in some cases.", "contents": "Vascular Dementia -- Evaluation -- Neuropsychological Testing. Neuropsychological testing is invaluable for fleshing out the full scope of cognitive and behavioral changes in all cases of MND, including vascular dementia. [13] Domain-specific cognitive assessment can aid in distinguishing vascular dementia from\u00a0Alzheimer disease based on neuropsychological profile; mixed dementia is more challenging to assess, making longitudinal assessment necessary in some cases."}
{"id": "article-31002_34", "title": "Vascular Dementia -- Evaluation -- Neuropsychological Testing", "content": "Neuropsychologists are also adept at sussing out the presence and burden of the so-called behavioral and psychiatric\u00a0adverse effects of dementia (BPSD) in vascular dementia. The evidence base for BPSD in vascular dementia lags well behind that for Alzheimer disease, meaning that the need for prospective, cross-sectional, and longitudinal studies of BPSD in vascular dementia is great. A recent expert panel strongly recommended using standardized protocols to address BPSD and care partner burden; the Neuropsychiatric Inventory (NPI)\u00a0was recommended for the former [19] and the Zarit Burden Index for the latter. [13]", "contents": "Vascular Dementia -- Evaluation -- Neuropsychological Testing. Neuropsychologists are also adept at sussing out the presence and burden of the so-called behavioral and psychiatric\u00a0adverse effects of dementia (BPSD) in vascular dementia. The evidence base for BPSD in vascular dementia lags well behind that for Alzheimer disease, meaning that the need for prospective, cross-sectional, and longitudinal studies of BPSD in vascular dementia is great. A recent expert panel strongly recommended using standardized protocols to address BPSD and care partner burden; the Neuropsychiatric Inventory (NPI)\u00a0was recommended for the former [19] and the Zarit Burden Index for the latter. [13]"}
{"id": "article-31002_35", "title": "Vascular Dementia -- Evaluation -- Current Trends in Evaluation", "content": "Currently, imaging modalities beyond MRI, such as FDG-, amyloid-, or tau-PET, have little utility in the clinical evaluation of MND and thus are best reserved for the research setting. This may change, however, as the emergence of new drugs for the treatment of Alzheimer disease may lead to some relaxation in the restrictions on the clinical availability of such tests.", "contents": "Vascular Dementia -- Evaluation -- Current Trends in Evaluation. Currently, imaging modalities beyond MRI, such as FDG-, amyloid-, or tau-PET, have little utility in the clinical evaluation of MND and thus are best reserved for the research setting. This may change, however, as the emergence of new drugs for the treatment of Alzheimer disease may lead to some relaxation in the restrictions on the clinical availability of such tests."}
{"id": "article-31002_36", "title": "Vascular Dementia -- Evaluation -- Current Trends in Evaluation", "content": "Similarly, the utility of biomarkers\u2014whether in CSF or blood\u2014in vascular dementia lags behind that of\u00a0Alzheimer disease\u00a0at this time. For example, interleukin 6 is a biomarker with the potential for discriminating between Alzheimer disease and vascular dementia,\u00a0but\u00a0minimal evidence and high inconsistency across studies limit its utility at this time. [20]", "contents": "Vascular Dementia -- Evaluation -- Current Trends in Evaluation. Similarly, the utility of biomarkers\u2014whether in CSF or blood\u2014in vascular dementia lags behind that of\u00a0Alzheimer disease\u00a0at this time. For example, interleukin 6 is a biomarker with the potential for discriminating between Alzheimer disease and vascular dementia,\u00a0but\u00a0minimal evidence and high inconsistency across studies limit its utility at this time. [20]"}
{"id": "article-31002_37", "title": "Vascular Dementia -- Treatment / Management", "content": "Prevention and control of vascular risk factors constitute the central approaches to managing vascular dementia, for which there is currently no curative pharmacologic treatment. Once vascular dementia is present, treatment\u00a0requires both pharmacologic and nonpharmacologic approaches.", "contents": "Vascular Dementia -- Treatment / Management. Prevention and control of vascular risk factors constitute the central approaches to managing vascular dementia, for which there is currently no curative pharmacologic treatment. Once vascular dementia is present, treatment\u00a0requires both pharmacologic and nonpharmacologic approaches."}
{"id": "article-31002_38", "title": "Vascular Dementia -- Treatment / Management", "content": "Prevention includes control of modifiable vascular risk factors. Notably, aspirin is no longer recommended for primary prevention, although it may still be used for secondary prevention. [21] A\u00a02019 meta-analysis revealed nonsuperiority among antihypertensives for dementia prevention among older adults; diuretic use suggested benefit in some studies, but results were inconsistent, and data in individuals younger than 65 were too limited to produce meaningful analyses. [22] A recent data analysis from the\u00a0Health and Retirement Study (HRS) revealed that\u00a0low LDL-C levels (<70 mg/dL, and especially <55 mg/dL) were associated with significantly slower cognitive decline. [23] Despite concerns about cognitive impairment associated with statin use exemplified by the\u00a0 FDA's changes to the safety label for statins, no evidence base has emerged to support this concern. Current guidance favors using statins because of their known cardiovascular benefit and LDL reduction for secondary prevention. [12]", "contents": "Vascular Dementia -- Treatment / Management. Prevention includes control of modifiable vascular risk factors. Notably, aspirin is no longer recommended for primary prevention, although it may still be used for secondary prevention. [21] A\u00a02019 meta-analysis revealed nonsuperiority among antihypertensives for dementia prevention among older adults; diuretic use suggested benefit in some studies, but results were inconsistent, and data in individuals younger than 65 were too limited to produce meaningful analyses. [22] A recent data analysis from the\u00a0Health and Retirement Study (HRS) revealed that\u00a0low LDL-C levels (<70 mg/dL, and especially <55 mg/dL) were associated with significantly slower cognitive decline. [23] Despite concerns about cognitive impairment associated with statin use exemplified by the\u00a0 FDA's changes to the safety label for statins, no evidence base has emerged to support this concern. Current guidance favors using statins because of their known cardiovascular benefit and LDL reduction for secondary prevention. [12]"}
{"id": "article-31002_39", "title": "Vascular Dementia -- Treatment / Management", "content": "Lifestyle modification is under intense study for its preventive promise in MND. In a recent retrospective analysis of long-term Korean data, exercise was significantly associated with a lower risk of incident dementia and, more specifically, a lower risk of post-stroke dementia development. [24] As important lifestyle modifications, a healthy diet, regular exercise, and active social engagement should all be emphasized. [25] [26] Potential geriatric syndromes such as falls, failure to thrive, malnutrition or undernutrition, elder abuse, and urinary incontinence should be evaluated and managed appropriately. Safety concerns should be addressed, which minimally should include assessing potential risks if the patient is living alone, still driving, or has routine access to firearms.", "contents": "Vascular Dementia -- Treatment / Management. Lifestyle modification is under intense study for its preventive promise in MND. In a recent retrospective analysis of long-term Korean data, exercise was significantly associated with a lower risk of incident dementia and, more specifically, a lower risk of post-stroke dementia development. [24] As important lifestyle modifications, a healthy diet, regular exercise, and active social engagement should all be emphasized. [25] [26] Potential geriatric syndromes such as falls, failure to thrive, malnutrition or undernutrition, elder abuse, and urinary incontinence should be evaluated and managed appropriately. Safety concerns should be addressed, which minimally should include assessing potential risks if the patient is living alone, still driving, or has routine access to firearms."}
{"id": "article-31002_40", "title": "Vascular Dementia -- Treatment / Management", "content": "No pharmacologic approaches are FDA-approved explicitly for vascular dementia. Cholinesterase inhibitors, which increase the availability of acetylcholine in the synaptic cleft and may have a salubrious effect on cerebral blood flow, are often used in an off-label fashion in vascular dementia. In contrast, they form the backbone of pharmacotherapy in Alzheimer disease. These agents have a mild-to-moderate benefit of slowing the progression of cognitive decline\u00a0in some patients, but they also have a significant\u00a0adverse effect profile, including gastrointestinal distress, symptomatic bradycardia, sleep disturbances, and weight loss. Cholinesterase inhibitors are not specific to treating vascular dementia but are reasonable to consider as there is considerable overlap of mixed Alzheimer dementia with vascular dementia.", "contents": "Vascular Dementia -- Treatment / Management. No pharmacologic approaches are FDA-approved explicitly for vascular dementia. Cholinesterase inhibitors, which increase the availability of acetylcholine in the synaptic cleft and may have a salubrious effect on cerebral blood flow, are often used in an off-label fashion in vascular dementia. In contrast, they form the backbone of pharmacotherapy in Alzheimer disease. These agents have a mild-to-moderate benefit of slowing the progression of cognitive decline\u00a0in some patients, but they also have a significant\u00a0adverse effect profile, including gastrointestinal distress, symptomatic bradycardia, sleep disturbances, and weight loss. Cholinesterase inhibitors are not specific to treating vascular dementia but are reasonable to consider as there is considerable overlap of mixed Alzheimer dementia with vascular dementia."}
{"id": "article-31002_41", "title": "Vascular Dementia -- Treatment / Management", "content": "Memantine, an NMDA receptor antagonist, is also used off-label for treating vascular dementia; its most common\u00a0adverse effects include dizziness and headache.\u00a0Newer monoclonal antibody agents (eg, aducanumab, lecanemab, and likely soon, donanemab) are approved for the treatment of mild Alzheimer dementia and remain controversial with significant\u00a0adverse effects and unclear degree of benefit. They are not recommended for the treatment of vascular dementia. [27] [28]", "contents": "Vascular Dementia -- Treatment / Management. Memantine, an NMDA receptor antagonist, is also used off-label for treating vascular dementia; its most common\u00a0adverse effects include dizziness and headache.\u00a0Newer monoclonal antibody agents (eg, aducanumab, lecanemab, and likely soon, donanemab) are approved for the treatment of mild Alzheimer dementia and remain controversial with significant\u00a0adverse effects and unclear degree of benefit. They are not recommended for the treatment of vascular dementia. [27] [28]"}
{"id": "article-31002_42", "title": "Vascular Dementia -- Treatment / Management", "content": "Nonpharmacologic approaches have been markedly less studied than pharmacologic, but this does not diminish their potential to help the vascular dementia dyad in some cases and to some extent. Such approaches include the collaboration of nutritionists, clinical social workers, cognitive rehabilitation, therapists (physical, occupational, and speech/language), audiologists, companion care services, and geriatric case managers to improve patient care. Ensuring that resources are in place for capacity for both financial and healthcare decisions is crucially important. Advance care planning is prudent.\u00a0When vascular dementia has progressed to its later or end stages, referral for palliative care or hospice.", "contents": "Vascular Dementia -- Treatment / Management. Nonpharmacologic approaches have been markedly less studied than pharmacologic, but this does not diminish their potential to help the vascular dementia dyad in some cases and to some extent. Such approaches include the collaboration of nutritionists, clinical social workers, cognitive rehabilitation, therapists (physical, occupational, and speech/language), audiologists, companion care services, and geriatric case managers to improve patient care. Ensuring that resources are in place for capacity for both financial and healthcare decisions is crucially important. Advance care planning is prudent.\u00a0When vascular dementia has progressed to its later or end stages, referral for palliative care or hospice."}
{"id": "article-31002_43", "title": "Vascular Dementia -- Differential Diagnosis", "content": "The main differential diagnosis for vascular dementia is Alzheimer Disease and mixed dementia presentations are quite common. In addition, the differential diagnosis process should review the patient's presentation for signs and symptoms of normal pressure hydrocephalus, excess alcohol consumption, emergence or exacerbation of bipolar and other mood disorders, and metabolic derangement (especially B12 and homocysteine).", "contents": "Vascular Dementia -- Differential Diagnosis. The main differential diagnosis for vascular dementia is Alzheimer Disease and mixed dementia presentations are quite common. In addition, the differential diagnosis process should review the patient's presentation for signs and symptoms of normal pressure hydrocephalus, excess alcohol consumption, emergence or exacerbation of bipolar and other mood disorders, and metabolic derangement (especially B12 and homocysteine)."}
{"id": "article-31002_44", "title": "Vascular Dementia -- Prognosis", "content": "Like all MND, vascular dementia is ultimately a terminal diagnosis. [29] Vascular dementia appears to have a poorer prognosis than Alzheimer disease. [30]", "contents": "Vascular Dementia -- Prognosis. Like all MND, vascular dementia is ultimately a terminal diagnosis. [29] Vascular dementia appears to have a poorer prognosis than Alzheimer disease. [30]"}
{"id": "article-31002_45", "title": "Vascular Dementia -- Prognosis", "content": "In one study of MND patients, those who experienced rapid mortality were slightly older at diagnosis, with lower MMSE scores and more depressive symptoms, plus a higher prevalence of cardiovascular risk factors, all of which had P values\u00a0less than\u00a00.05.\u00a0Alzheimer disease was most common among individuals with rapid mortality, but it was relatively less common in the group without rapid mortality. Among those with rapid mortality, vascular dementia, frontotemporal dementia, and Creutzfeldt-Jakob disease occurred more frequently than Alzheimer disease. [31] For vascular dementia, published papers note a life expectancy range\u00a0of 3 to 5 years.", "contents": "Vascular Dementia -- Prognosis. In one study of MND patients, those who experienced rapid mortality were slightly older at diagnosis, with lower MMSE scores and more depressive symptoms, plus a higher prevalence of cardiovascular risk factors, all of which had P values\u00a0less than\u00a00.05.\u00a0Alzheimer disease was most common among individuals with rapid mortality, but it was relatively less common in the group without rapid mortality. Among those with rapid mortality, vascular dementia, frontotemporal dementia, and Creutzfeldt-Jakob disease occurred more frequently than Alzheimer disease. [31] For vascular dementia, published papers note a life expectancy range\u00a0of 3 to 5 years."}
{"id": "article-31002_46", "title": "Vascular Dementia -- Complications", "content": "As vascular dementia progresses from mild to moderate, challenging behaviors often become more common, and the care partner burden often increases. Challenging behaviors can include the emergence of delusions, visual hallucinations, and paranoia, among others. Care partner counseling is essential here, and care partners can benefit greatly from instruction about redirection and other soothing approaches; it is crucial to underscore that there is simply no such thing as one pill or any medication combination that can alleviate all challenging behaviors. As vascular dementia enters its end stages, functional concerns often predominate, as patients may develop problems with gait, aspiration, falls, pressure sores or ulcers, and burdensome hospitalizations.", "contents": "Vascular Dementia -- Complications. As vascular dementia progresses from mild to moderate, challenging behaviors often become more common, and the care partner burden often increases. Challenging behaviors can include the emergence of delusions, visual hallucinations, and paranoia, among others. Care partner counseling is essential here, and care partners can benefit greatly from instruction about redirection and other soothing approaches; it is crucial to underscore that there is simply no such thing as one pill or any medication combination that can alleviate all challenging behaviors. As vascular dementia enters its end stages, functional concerns often predominate, as patients may develop problems with gait, aspiration, falls, pressure sores or ulcers, and burdensome hospitalizations."}
{"id": "article-31002_47", "title": "Vascular Dementia -- Consultations", "content": "In vascular dementia, as with all of MND, a multidisciplinary care team\u00a0approach is necessary to effectively\u00a0care for\u00a0the patient and the care partner, known as the patient-partner dyad, (see the section \"Enhancing Team Outcomes\"). Consultations with geriatric neurology, psychiatry, and neuropsychology are recommended during the diagnostic evaluation. Consultations with social workers, speech pathologists, and occupational and physical therapists are almost always helpful during follow-up care. Some patients might also benefit from consultation with a nutritionist, a fitness instructor, an audiologist, or a clinical nurse navigator who can help direct the dyad to social services and other supports for older adults with cognitive decline and impairment.", "contents": "Vascular Dementia -- Consultations. In vascular dementia, as with all of MND, a multidisciplinary care team\u00a0approach is necessary to effectively\u00a0care for\u00a0the patient and the care partner, known as the patient-partner dyad, (see the section \"Enhancing Team Outcomes\"). Consultations with geriatric neurology, psychiatry, and neuropsychology are recommended during the diagnostic evaluation. Consultations with social workers, speech pathologists, and occupational and physical therapists are almost always helpful during follow-up care. Some patients might also benefit from consultation with a nutritionist, a fitness instructor, an audiologist, or a clinical nurse navigator who can help direct the dyad to social services and other supports for older adults with cognitive decline and impairment."}
{"id": "article-31002_48", "title": "Vascular Dementia -- Deterrence and Patient Education", "content": "Diagnosis of vascular dementia allows physicians to provide patients and caregivers with valuable counseling\u00a0about secondary prevention, safety, advance care planning, and caregiver burden. Secondary prevention discussions should also focus on a healthy diet, exercise, cognitive stimulation, and socialization. The overall holistic goal is to ensure safety while optimizing independence and supporting the care partner.", "contents": "Vascular Dementia -- Deterrence and Patient Education. Diagnosis of vascular dementia allows physicians to provide patients and caregivers with valuable counseling\u00a0about secondary prevention, safety, advance care planning, and caregiver burden. Secondary prevention discussions should also focus on a healthy diet, exercise, cognitive stimulation, and socialization. The overall holistic goal is to ensure safety while optimizing independence and supporting the care partner."}
{"id": "article-31002_49", "title": "Vascular Dementia -- Enhancing Healthcare Team Outcomes", "content": "Each person with vascular dementia usually has a care partner, and the patient-partner dyad becomes the central focus of any therapeutic or educational intervention. The needs of individuals with vascular dementia are extensive, often requiring care beyond the traditional confines of medical practice, including pharmacologic and nonpharmacologic interventions. For this reason, the preferred approach to caring for the vascular dementia dyad is a multidisciplinary team,\u00a0which can work in an integrated or parallel manner, including both synchronous and asynchronous patterns. [32]", "contents": "Vascular Dementia -- Enhancing Healthcare Team Outcomes. Each person with vascular dementia usually has a care partner, and the patient-partner dyad becomes the central focus of any therapeutic or educational intervention. The needs of individuals with vascular dementia are extensive, often requiring care beyond the traditional confines of medical practice, including pharmacologic and nonpharmacologic interventions. For this reason, the preferred approach to caring for the vascular dementia dyad is a multidisciplinary team,\u00a0which can work in an integrated or parallel manner, including both synchronous and asynchronous patterns. [32]"}
{"id": "article-31002_50", "title": "Vascular Dementia -- Enhancing Healthcare Team Outcomes", "content": "Geriatricians, psychiatrists, and neurologists are essential for guiding the diagnostic workup and initiating behavioral and pharmacological treatment interventions. Neuropsychologists contribute domain-specific cognitive evaluations and can often elucidate areas of relative cognitive strengths and weaknesses, allowing for the development of focused treatment plans. In some cases, neuropsychologists can also offer cognitive rehabilitation, which was associated with improved working memory and attention in\u00a0a recent study. [33]", "contents": "Vascular Dementia -- Enhancing Healthcare Team Outcomes. Geriatricians, psychiatrists, and neurologists are essential for guiding the diagnostic workup and initiating behavioral and pharmacological treatment interventions. Neuropsychologists contribute domain-specific cognitive evaluations and can often elucidate areas of relative cognitive strengths and weaknesses, allowing for the development of focused treatment plans. In some cases, neuropsychologists can also offer cognitive rehabilitation, which was associated with improved working memory and attention in\u00a0a recent study. [33]"}
{"id": "article-31002_51", "title": "Vascular Dementia -- Enhancing Healthcare Team Outcomes", "content": "Physical therapists can help vascular dementia patients optimize their physical conditioning and maintain safe mobility, reducing care partner stress and delaying the need for institutionalization. Specially-trained occupational therapists can assess older adults for driving safety, [34] in addition to providing assistive devices to aid with ambulation, dressing, toileting, eating, and other functional activities.", "contents": "Vascular Dementia -- Enhancing Healthcare Team Outcomes. Physical therapists can help vascular dementia patients optimize their physical conditioning and maintain safe mobility, reducing care partner stress and delaying the need for institutionalization. Specially-trained occupational therapists can assess older adults for driving safety, [34] in addition to providing assistive devices to aid with ambulation, dressing, toileting, eating, and other functional activities."}
{"id": "article-31002_52", "title": "Vascular Dementia -- Enhancing Healthcare Team Outcomes", "content": "Nutritionists can help the dyad select foods that emphasize appeal while also helping to maintain adequate protein-calorie nutrition and hydration. Audiologists can assess hearing and offer appropriate treatment with hearing amplification to improve sensory input and achieve maximal retention of oral communication. Speech therapists are essential for monitoring and supporting swallowing function. Social workers and clinical nurse navigators are crucial for helping vascular dementia dyads access social services, including support groups, respite care, financial services, community-based programs, and supports designed specifically for care partners. Advanced-care planning should explore the patient\u2019s values related to quality of life, interventions, and longevity.", "contents": "Vascular Dementia -- Enhancing Healthcare Team Outcomes. Nutritionists can help the dyad select foods that emphasize appeal while also helping to maintain adequate protein-calorie nutrition and hydration. Audiologists can assess hearing and offer appropriate treatment with hearing amplification to improve sensory input and achieve maximal retention of oral communication. Speech therapists are essential for monitoring and supporting swallowing function. Social workers and clinical nurse navigators are crucial for helping vascular dementia dyads access social services, including support groups, respite care, financial services, community-based programs, and supports designed specifically for care partners. Advanced-care planning should explore the patient\u2019s values related to quality of life, interventions, and longevity."}
{"id": "article-31002_53", "title": "Vascular Dementia -- Enhancing Healthcare Team Outcomes", "content": "In summary, as with all MND, no\u00a0disease-modifying\u00a0treatments exist for vascular dementia. Management of vascular dementia ideally requires prevention through effective control of vascular risk factors. [35] [36] [37]  These risk factors\u00a0include hypertension, fasting blood glucose, lipid profiles, diet, body mass index, physical activity, and smoking. With adequate control of these risk factors, vascular dementia may be nonneurodegenerative.\u00a0Once vascular brain injury has occurred, symptomatic management should be offered and secondary prevention pursued. [12]", "contents": "Vascular Dementia -- Enhancing Healthcare Team Outcomes. In summary, as with all MND, no\u00a0disease-modifying\u00a0treatments exist for vascular dementia. Management of vascular dementia ideally requires prevention through effective control of vascular risk factors. [35] [36] [37]  These risk factors\u00a0include hypertension, fasting blood glucose, lipid profiles, diet, body mass index, physical activity, and smoking. With adequate control of these risk factors, vascular dementia may be nonneurodegenerative.\u00a0Once vascular brain injury has occurred, symptomatic management should be offered and secondary prevention pursued. [12]"}
{"id": "article-31002_54", "title": "Vascular Dementia -- Enhancing Healthcare Team Outcomes", "content": "Current guidance recommends using antiplatelet agents for secondary prevention of cerebrovascular events but\u00a0not\u00a0primary prevention. [21] Pharmacological approaches to vascular dementia include acetylcholinesterase inhibitors and or memantine, although, in vascular dementia, their use is off-label. Though completed studies are\u00a0currently few, they suggest that cognitive rehabilitation may have promise for treating vascular dementia; completed studies have shown improvements in global cognitive function, attention, and working memory. [33] Whether to offer these interventions necessitates carefully conversing with patients and caregivers, weighing the benefits and\u00a0adverse effects, and individualizing recommendations to achieve realistic goals and optimize patient outcomes.", "contents": "Vascular Dementia -- Enhancing Healthcare Team Outcomes. Current guidance recommends using antiplatelet agents for secondary prevention of cerebrovascular events but\u00a0not\u00a0primary prevention. [21] Pharmacological approaches to vascular dementia include acetylcholinesterase inhibitors and or memantine, although, in vascular dementia, their use is off-label. Though completed studies are\u00a0currently few, they suggest that cognitive rehabilitation may have promise for treating vascular dementia; completed studies have shown improvements in global cognitive function, attention, and working memory. [33] Whether to offer these interventions necessitates carefully conversing with patients and caregivers, weighing the benefits and\u00a0adverse effects, and individualizing recommendations to achieve realistic goals and optimize patient outcomes."}
{"id": "article-31002_55", "title": "Vascular Dementia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Vascular Dementia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}